Health Blog

Commercialization of stem cell therapy

So far, we must know about positive applications of these therapies, which are transplanted into the body with living cells to be treated, or eliminate disease from the patient’s body. The most common type of cell therapy is hematopoietic therapy. Harvest from the donor body for the host to develop the bone marrow, it is well-known cell-based therapy, with self-renewal and differentiation capabilities into many types of cells.

Stem cell therapy has the potential to treat various disorders, especially blood and disorders related to immune. These various therapies include alogenic cell therapy, autologous therapy, and this mesencheme has shown a large terrace to heal many medical conditions such as sclerosis, spinal cord injury, diabetes and strokes in clinical trials. Recently, we have a gift of induced pluripotene stem cells, has the same characteristics as adult embryonic stem cells that can be cultured to produce embryonic stem cells. These cells are important for other key network engineering.

Over the past few decades, cell therapy has received medical and commercial success to emerge as a new therapeutic choice for many cellular dysfunctional diseases. If the data will be trusted, the global market of stem cell therapy has touched an average of $ 410 million in 2009, and the market is expected to double and reach a total of 100 million people in the US.

And because of the many medical benefits, medical companies and research institutions want to bring their clinical applications from the bench to the bedside.

Even though it is open to many controversies and debates, we have enough evidence to prove that therapy is indeed an effective therapeutic application to overcome various diseases, including cosmetic procedures such as hair regrowth, redefining the skin and others.

In addition, the more cell-based clinical lines remain valid for the potential of stem cell efficiency and its application. A recent study in June 2010 highlighted cell therapy capabilities up to 2000 (around) clinical studies on biomedical research.

While embryonic cell manipulation is limited and controversial, the opportunity is greater to develop engineering networks from IPSC worthy of medical intervention in serious conditions. And this is the underlying reason, why the public and the community demand more clinical trials than stem cell-based therapy and their application in the medical field.

Therefore, it is important to commercialize the use of stem cells for rapid development of biomedical research, and improve public health through awareness. Some important aspects of commercialization of stem cell therapy are as follows as below.

Commercialization helps develop new technology and intellectual property for certain stem cell research, adding their value in the therapeutic market.
It aims to stimulate economic growth and improve public health.
It comes on grants or funds for use in clinical research to produce more commercially proper service and products on the market.
It is important for the translation of public knowledge.
Apart from the growth factors of the commercialization of stem cell therapy, it faces many challenges from certain government agencies, which prevents its positive efforts from creating effective care and curative for many diseases that cannot be cured.

Comments are closed.